Levocetirizine Hydrochloride

Phase 2Small molecule

SSun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Levocetirizine Hydrochloride is one of 9 small molecule programs targeting Nab-paclitaxel. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Nab-PaclitaxelNot yet recruiting

Nab-PaclitaxelPhase 2

Not yet recruiting

Competition

Competitive Landscape

8 competitors in Nab-Paclitaxel

#DrugCompanyPhaseTrials

Abraxane

Bristol-Myers Squibb

Phase 2

19 2

Gemzar

Johnson & Johnson

Phase 2

3 3

Beyfortus

BeiGene

Phase 2

2 4

Tuoyi

CCoherus Oncology, Inc.

Phase 2

3 5

Tarceva

OOSI Pharmaceuticals

Phase 2

2 6

Tuoyi

SSun Yat-sen University

Phase 2

1 7

Camrelizumab Plus Apatinib

PPeking University Cancer Hospital & Institute

Phase 2

1 8

PD-1 Inhibitior

TTianjin Medical University Second Hospital

Phase 2

1 9

Levocetirizine Hydrochloride

SSun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2027

Phase 2Not yet recruiting

Nab-Paclitaxel

NCT06632405

Clinical

Trials by Indication[1]

Nab-paclitaxel1 trial

A Trial of Camrelizumab Plus Nab-paclitaxel and Levocetirizine in Metastatic or Recurrent TNBC

Not yet recruiting·SSun Yat-Sen Memorial Hospital of Sun Yat-Sen University·Phase 2·NCT06632405·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Levocetirizine Hydrochloride. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Levocetirizine Hydrochloride compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Levocetirizine Hydrochloride. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: SSun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Levocetirizine Hydrochloride

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2027

Trials by Indication[1]

Nab-paclitaxel1 trial

References

Drug Info

Quick Facts

Related News